Cancer statistics, 2023
Тип публикации: Journal Article
Дата публикации: 2023-01-12
scimago Q1
wos Q1
white level БС1
SJR: 145.004
CiteScore: 1154.2
Impact factor: 232.4
ISSN: 00079235, 15424863
PubMed ID:
36633525
Oncology
Hematology
Краткое описание
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus‐associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
50
100
150
200
250
300
350
400
450
|
|
|
Cancers
424 публикации, 3.04%
|
|
|
Frontiers in Oncology
381 публикация, 2.73%
|
|
|
Scientific Reports
293 публикации, 2.1%
|
|
|
bioRxiv
250 публикаций, 1.79%
|
|
|
International Journal of Molecular Sciences
218 публикаций, 1.56%
|
|
|
Frontiers in Immunology
203 публикации, 1.46%
|
|
|
BMC Cancer
162 публикации, 1.16%
|
|
|
Discover Oncology
151 публикация, 1.08%
|
|
|
Heliyon
125 публикаций, 0.9%
|
|
|
Frontiers in Pharmacology
112 публикаций, 0.8%
|
|
|
Cancer Medicine
103 публикации, 0.74%
|
|
|
Cureus
86 публикаций, 0.62%
|
|
|
Cancer Letters
73 публикации, 0.52%
|
|
|
Advanced Science
73 публикации, 0.52%
|
|
|
Gynecologic Oncology
69 публикаций, 0.5%
|
|
|
Annals of Surgical Oncology
68 публикаций, 0.49%
|
|
|
International Journal of Biological Macromolecules
68 публикаций, 0.49%
|
|
|
medRxiv
65 публикаций, 0.47%
|
|
|
Biomedicines
64 публикации, 0.46%
|
|
|
Journal of Cancer Research and Clinical Oncology
63 публикации, 0.45%
|
|
|
Journal of Translational Medicine
63 публикации, 0.45%
|
|
|
Cancer Cell International
56 публикаций, 0.4%
|
|
|
PLoS ONE
55 публикаций, 0.39%
|
|
|
Journal of Clinical Medicine
55 публикаций, 0.39%
|
|
|
Cell Death and Disease
54 публикации, 0.39%
|
|
|
Biomedicine and Pharmacotherapy
52 публикации, 0.37%
|
|
|
Diagnostics
51 публикация, 0.37%
|
|
|
Pharmaceutics
49 публикаций, 0.35%
|
|
|
iScience
49 публикаций, 0.35%
|
|
|
50
100
150
200
250
300
350
400
450
|
Издатели
|
500
1000
1500
2000
2500
3000
3500
|
|
|
Elsevier
3098 публикаций, 22.23%
|
|
|
Springer Nature
3088 публикаций, 22.16%
|
|
|
MDPI
1402 публикации, 10.06%
|
|
|
Wiley
1232 публикации, 8.84%
|
|
|
Frontiers Media S.A.
961 публикация, 6.9%
|
|
|
Taylor & Francis
490 публикаций, 3.52%
|
|
|
openRxiv
315 публикаций, 2.26%
|
|
|
American Chemical Society (ACS)
290 публикаций, 2.08%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
271 публикация, 1.94%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
269 публикаций, 1.93%
|
|
|
AME Publishing Company
215 публикаций, 1.54%
|
|
|
SAGE
185 публикаций, 1.33%
|
|
|
Oxford University Press
176 публикаций, 1.26%
|
|
|
American Association for Cancer Research (AACR)
122 публикации, 0.88%
|
|
|
Royal Society of Chemistry (RSC)
116 публикаций, 0.83%
|
|
|
Bentham Science Publishers Ltd.
107 публикаций, 0.77%
|
|
|
Research Square Platform LLC
102 публикации, 0.73%
|
|
|
American Society of Clinical Oncology (ASCO)
97 публикаций, 0.7%
|
|
|
BMJ
92 публикации, 0.66%
|
|
|
Spandidos Publications
86 публикаций, 0.62%
|
|
|
Baishideng Publishing Group
66 публикаций, 0.47%
|
|
|
Public Library of Science (PLoS)
61 публикация, 0.44%
|
|
|
Impact Journals
46 публикаций, 0.33%
|
|
|
De Gruyter Brill
44 публикации, 0.32%
|
|
|
Mary Ann Liebert
31 публикация, 0.22%
|
|
|
S. Karger AG
31 публикация, 0.22%
|
|
|
Georg Thieme Verlag KG
29 публикаций, 0.21%
|
|
|
American Association for the Advancement of Science (AAAS)
29 публикаций, 0.21%
|
|
|
PeerJ
28 публикаций, 0.2%
|
|
|
500
1000
1500
2000
2500
3000
3500
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
14k
Всего цитирований:
14092
Цитирований c 2025:
4706
(33.77%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Siegel R. L. et al. Cancer statistics, 2023 // Ca-A Cancer Journal for Clinicians. 2023. Vol. 73. No. 1. pp. 17-48.
ГОСТ со всеми авторами (до 50)
Скопировать
Siegel R. L., Miller K. D., Wagle N. S., Jemal A. Cancer statistics, 2023 // Ca-A Cancer Journal for Clinicians. 2023. Vol. 73. No. 1. pp. 17-48.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3322/caac.21763
UR - https://doi.org/10.3322/caac.21763
TI - Cancer statistics, 2023
T2 - Ca-A Cancer Journal for Clinicians
AU - Siegel, Rebecca L.
AU - Miller, Kimberly D
AU - Wagle, Nikita Sandeep
AU - Jemal, Ahmedin
PY - 2023
DA - 2023/01/12
PB - Wiley
SP - 17-48
IS - 1
VL - 73
PMID - 36633525
SN - 0007-9235
SN - 1542-4863
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2023_Siegel,
author = {Rebecca L. Siegel and Kimberly D Miller and Nikita Sandeep Wagle and Ahmedin Jemal},
title = {Cancer statistics, 2023},
journal = {Ca-A Cancer Journal for Clinicians},
year = {2023},
volume = {73},
publisher = {Wiley},
month = {jan},
url = {https://doi.org/10.3322/caac.21763},
number = {1},
pages = {17--48},
doi = {10.3322/caac.21763}
}
Цитировать
MLA
Скопировать
Siegel, Rebecca L., et al. “Cancer statistics, 2023.” Ca-A Cancer Journal for Clinicians, vol. 73, no. 1, Jan. 2023, pp. 17-48. https://doi.org/10.3322/caac.21763.
Ошибка в публикации?